Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.

MLA

Dadu, Ramona, et al. “Calcium-Sensing Receptor Autoantibody-Mediated Hypoparathyroidism Associated with Immune Checkpoint Inhibitor Therapy: Diagnosis and Long-Term Follow-Up.” Journal for Immunotherapy of Cancer, vol. 8, no. 1, June 2020. EBSCOhost, https://doi.org/10.1136/jitc-2020-000687.

APA

Dadu, R., Rodgers, T. E., Trinh, V. A., Kemp, E. H., Cubb, T. D., Patel, S., Simon, J. M., Burton, E. M., & Tawbi, H. (2020). Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up. Journal for Immunotherapy of Cancer, 8(1). https://doi.org/10.1136/jitc-2020-000687

Chicago

Dadu, Ramona, Theresa E Rodgers, Van A Trinh, Elizabeth Helen Kemp, Trisha D Cubb, Sapna Patel, Julie M Simon, Elizabeth M Burton, and Hussein Tawbi. 2020. “Calcium-Sensing Receptor Autoantibody-Mediated Hypoparathyroidism Associated with Immune Checkpoint Inhibitor Therapy: Diagnosis and Long-Term Follow-Up.” Journal for Immunotherapy of Cancer 8 (1). doi:10.1136/jitc-2020-000687.